NCT06984276 Ultrasound Guided Bilateral Pectoral Nerve Block Versus Bilateral Transverse Thoracic Plane Block In Pediatric Patients Undergoing Corrective Cardiac Surgeries Requiring Cardiopulmonary Bypass Via Median Sternotomy
| NCT ID | NCT06984276 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Ultrasound |
| Study Type | INTERVENTIONAL |
| Enrollment | 81 participants |
| Start Date | 2024-09-30 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 81 participants in total. It began in 2024-09-30 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, double-blinded, study aims to compare the efficacy of intraoperative and postoperative pain control while using bilateral ultrasound guided the pectoral nerves (PECS) versus transversus thoracic muscle plane block (TTPB) in pediatric patients undergoing corrective cardiac surgeries.
Eligibility Criteria
Inclusion Criteria: * Age: 6 months - 7 years. * Gender: both sexs . * Risk Adjustment for Congenital Heart Surgery (RACHS) II and III. * Patients undergoing cardiac surgeries requiring cardiopulmonary bypass with midline sternotomy incision. Exclusion Criteria: * Patients whose parents or legal guardians refuse to participate. * Preoperative mechanical ventilation. * Patients in coma, mental retardation, neurological disease, or on drugs affecting the behaviour. * Preoperative inotropic drug infusion. * (Bleeding disorders (drug induced i.e., coumadin; or genetic e.g. hemophilia; or acquired e.g. disseminated intravascular coagulation \[DIC\]), coagulopathy: Partial Thromboplastin Time (PTT) \> 40 seconds, International Normalized Ratio (INR) \> 1.4, platelet count \< 100x10⁹. * Known or suspected allergy to any of the studied drugs. * Severe pulmonary hypertension (mean resting blood pressure in pulmonary arteries is above 70mmHg). * Cardiopulmonary bypass time more than 90 minutes. * local infection. * Significant Renal impairment (creatinine more than 1.2mg/dl) * Aortic cross-clamp time more than 45 minutes. * Total time from induction till intensive Care Unit (ICU) transfer more than 4 hours and 30 mins.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06984276 clinical trial?
This trial is open to participants of all sexes, aged 6 Months or older, up to 7 Years, studying Ultrasound. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06984276 currently recruiting?
Yes, NCT06984276 is actively recruiting participants. Contact the research team at maielfiky45@gmail.com for enrollment information.
Where is the NCT06984276 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT06984276 clinical trial?
NCT06984276 is sponsored by Cairo University. The trial plans to enroll 81 participants.